Last reviewed · How we verify
NCT07000097: 3DPAD-1
Use of Three-Dimensional Printed Models for Endovascular Planning and Follow-up in Patients Affected by Aorto-Iliac-Femoral-Popliteal Arterial Disease Undergoing Balloon Angioplasty. A Single-center, Single-blind Randomized Controlled Trial
NA trial testing PTA planning supported by 3D-printed model in Peripheral Artery Disease (PAD) in 100 participants. Participants enrolled and being followed up; not accepting new ones.
9 December 2024
Quick facts
| Lead sponsor | Azienda Ospedaliero-Universitaria di Parma |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 5 January 2022 |
| Primary completion | 9 December 2024 |
| Estimated completion | 30 September 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- PTA planning supported by 3D-printed model
- PTA (Standard of Care) — full drug profile →
Conditions studied
- Peripheral Artery Disease (PAD) — all drugs for Peripheral Artery Disease (PAD) →
Sponsor
Azienda Ospedaliero-Universitaria di Parma — full company profile →
Who can join
Adults 18 to 89, any sex, with Peripheral Artery Disease (PAD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Lower extremity peripheral arterial disease is a major health problem. Currently, balloon angioplasty represents the most commonly performed treatment for patients affected by vascular claudication or critical limb ischemia. Pre-operative planning for aorto-iliac-femoral-popliteal atherosclerotic disease is a complex procedure, since an inappropriate strategy may lead to peri-operative complications. The aim of this study is to propose an innovative planning strategy for balloon angioplasty with the support of complex 3D printed models. The goal is to reduce peri-operative complications and overall costs, while improving technical success and mid-term patency of revascularizations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07000097
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peripheral Artery Disease (PAD)
Currently open trials in the same condition.
- NCT07226193 — Detecting Peripheral Artery Disease With the Pulse · NA · recruiting
- NCT07313410 — Using Near-Infrared Light to Better Understand Peripheral Artery Disease · recruiting
- NCT07169045 — Validity and Reliability of the 6-minute Stepper Test in Patients With Peripheral Artery Disease · recruiting
- NCT06687590 — Serranator POINT FORCE Registry · recruiting
- NCT06605209 — Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. · NA · recruiting
Other Azienda Ospedaliero-Universitaria di Parma trials
Trials by the same sponsor.
- NCT07360366 — Interprofessional Collaboration in the Cardiac Intensive Care Unit (CICU): An Action-Research Training Project · NA · not yet recruiting
- NCT06888167 — Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function. · NA · recruiting
- NCT06876818 — Predictive Cardio-Metabolic Trascrictomics Trajectories In The Barilla Offspring Follow-Up Study · active not recruiting
- NCT07419178 — A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemoki · NA · recruiting
- NCT05936944 — Role of Natural Light in the Prevention of Delirium After Cardiac Surgery: a Prospective Observational Study With Histor · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07000097 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria di Parma
- Last refreshed: 2 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07000097.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing